Combined Advanced Targeted Therapy for Inflammatory Bowel Disease

Clinical trial NCT07660289 · COMPLETED

Trial details

NCT number: NCT07660289
Sponsor: Xijing Hospital of Digestive Diseases
Status: COMPLETED
Study type: OBSERVATIONAL

IBD (Inflammatory Bowel Disease)Combined Advanced Targeted Therapy Combination Therapy

Start date: 2023-04-20
Primary completion: 2026-05-10
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.